Next Generation Sequencing. Harness Its Power.
Data complexity and efficient processing are two of the major challenges facing NGS-based methods. From gaining a deeper understanding of therapies, drug targets, disease mechanisms, and patient molecular profiles to streamlining the development of life-changing therapies such as vaccines, antibodies, and CGTs – NGS can revolutionize the process. How can you facilitate collaboration and faster time-to-insights to accelerate decision making and also maintain a central FAIR data hub?
This is where Genedata comes in.
Our Customers
- Any Technology. One NGS Data Management Solution.
- Automate. Entire NGS Lifecycle Workflow.
- Decision-Making. Accelerated.
- Reporting. Simplified. Compliant.
- AI-Driven Insights. Structured Data.
Any Technology. One NGS Data Management Solution.
- Unify sample registration and workflow tracking on a central system for NGS data from any sequencing technology, including Illumina, Pacific Biosciences, and Oxford Nanopore.
- Harmonize data generated by all NGS-based methods, including whole genome sequencing, transcriptomics, single-cell RNA sequencing, and spatial genomics.
- Combine and track NGS datasets from internal repositories, in-house laboratory sequencers, or external sequencing vendors. Easily integrate data from partnering CROs.
Automate. Entire NGS Lifecycle Workflow.
- Increase the efficiency and accuracy of data management, curation, and analysis through automated, configurable workflows that reduce the time and resources required for data processing.
- Streamline the acquisition, structuring, and harmonization of large and complex NGS datasets using intuitive guides and analysis-ready data for downstream visualization and interpretation.
- Incorporate existing external or community standard pipelines such as Nextflow to further extend automated data processing, QC, and analysis capabilities.
Decision-Making. Accelerated.
- Make faster and more accurate decisions using a unique go/no-go traffic light system, improving process efficiency and cross-functional team collaboration.
- Implement Multi-Attribute Method for standard NGS analyses that is fully traceable and linked to each NGS data sample and reference libraries.
- Leverage a highly performant analytics environment to integrate multi-omics data and use advanced programming languages such as R, Python, and the command line to process and analyze data in a high-security environment.
- Easily find and access data for insight generation with the metadata-powered organization of data sets and results.
Reporting. Simplified. Compliant.
- Adopt a validation-ready system with embedded data integrity, privacy, and security and benefit from expertise and documentation required to implement NGS in GxP environments.
- Automatically generate comprehensive 21 CFR Part 11-compliant reports that contain all critical details required by regulatory agencies.
- Deliver high-quality regulatory submissions with templates for computer system validation testing, automatically generated time-stamped reports, and out-of-the-box safeguards, such as audit trails and user access controls.
AI-Driven Insights. Structured Data.
- Use Genedata’s essential structured data foundation for AI/ML, providing you with a data system to both manage your data and guide your future biotherapeutics R&D projects.
- From early discovery to clinical development, interactive visualizations and comprehensive biological insights becomes easy allowing you to identify and validate drug targets to enhance your pipelines across different therapeutic areas.
- By simplifying access to multi-source data and facilitating integrative analyses with a diverse range of analytical solutions, Genedata Biopharma drives the evaluation of drug efficacy.
- Leverage the platform to identify the best-performing biotherapeutics for a given target or a given indication.
Customer Stories
Cell Line Characterization: Sequence Variant Analysis
Learn how Boehringer Ingelheim streamlined RNA-Seq analysis workflows to enhance CHO cell line characterization with superior mutation detection and improved transgene expression screening.
Adventitious Virus Detection Using NGS-Based Workflows
Discover how Johnson & Johnson is using Genedata Selector and NGS for biosafety testing, detecting hard-to-find contaminants, and improving quality control with approach-agnostic workflows.
Overcoming Cell Therapy Biosafety Challenges
Learn how Astellas is using NGS and Genedata Selector to improve biosafety and data integration for cell therapy products.
Gene Therapy QC with Long-Read Sequencing
Learn more how Fujifilm automates gene therapy QC assays with long-read NGS, reducing analysis time by 90% and enhancing data accuracy using Genedata Selector.